References

Transplantation of living nuclei from blastula cells into enucleated frogs’ eggs

10.1073/pnas.38.5.455 · 1952 · External reference

Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei

10.1038/182064a0 · 1958 · External reference

Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells

10.1126/science.1116447 · 2005 · External reference

Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells

10.1016/s0960-9822(01)00459-6 · 2001 · External reference

Nuclear reprogramming and pluripotency

10.1038/nature04955 · 2006 · External reference

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

10.1016/j.cell.2006.07.024 · 2006 · External reference

Generation of germline-competent induced pluripotent stem cells

10.1038/nature05934 · 2007 · External reference

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

10.1016/j.cell.2007.11.019 · 2007 · External reference

Induced pluripotent stem cell lines derived from human somatic cells

10.1126/science.1151526 · 2007 · External reference

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

10.1038/nature05944 · 2007 · External reference

Reprogramming of human somatic cells to pluripotency with defined factors

10.1038/nature06534 · 2008 · External reference

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

10.1038/nbt.1503 · 2008 · External reference

Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes

10.1371/journal.pone.0011373 · 2010 · External reference

Generation of induced pluripotent stem cells from human blood

10.1182/blood-2009-02-204800 · 2009 · External reference

Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2

10.1016/j.stem.2009.09.008 · 2009 · External reference

Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells

10.1089/scd.2011.0435 · 2012 · External reference

Direct reprogramming of human neural stem cells by OCT4

10.1038/nature08436 · 2009 · External reference

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells

10.1073/pnas.0908450106 · 2009 · External reference

Generation of human induced pluripotent stem cells from urine samples

10.1038/nprot.2012.115 · 2012 · External reference

Generation of functional murine cardiac myocytes from induced pluripotent stem cells

10.1161/circulationaha.108.778795 · 2008 · External reference

Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells

10.1161/circulationaha.108.769562 · 2008 · External reference

Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model

2012 · External reference

Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling

10.1161/circulationaha.112.000641 · 2013 · External reference

Intramyocardial injection of pig pluripotent stem cells improves left ventricular function and perfusion: a study in a porcine model of acute myocardial infarction

10.1371/journal.pone.0066688 · 2013 · External reference

Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells

10.1016/j.jacc.2014.04.056 · 2014 · External reference

Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application

10.1016/j.stemcr.2013.12.007 · 2014 · External reference

Rethinking differentiation: stem cells, regeneration, and plasticity

10.1016/j.cell.2014.02.041 · 2014 · External reference

Concise review: drug discovery in the age of the induced pluripotent stem cell

10.5966/sctm.2013-0162 · 2014 · External reference

Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges

10.1161/circresaha.114.300556 · 2014 · External reference

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells

10.1161/circulationaha.109.865154 · 2009 · External reference

Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction

10.2217/rme.10.103 · 2011 · External reference

Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium

10.1161/circresaha.116.304668 · 2015 · External reference

Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart

10.1371/journal.pone.0019012 · 2011 · External reference

Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response

10.1096/fj.06-6769com · 2007 · External reference

Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 T

10.1002/mrm.20702 · 2006 · External reference

Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart

10.1161/circresaha.110.240010 · 2011 · External reference

Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart

10.1007/s00395-012-0301-5 · 2012 · External reference

Chemically defined generation of human cardiomyocytes

10.1038/nmeth.2999 · 2014 · External reference

Abstract 19831: in vivo molecular imaging of human pluripotent stem cell-derived cardiomyocytes in a murine myocardial injury model via a safe harbor integration of a reporter gene

10.1161/circ.130.suppl_2.19831 · 2014 · External reference

Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells

10.1371/journal.pone.0023667 · 2011 · External reference

Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction

10.1093/eurheartj/ehr166 · 2011 · External reference

Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function

10.1016/j.jacc.2011.06.062 · 2011 · External reference

Molecular strategy to reduce in vivo collagen barrier promotes entry of NCX1 positive inducible pluripotent stem cells (iPSC(NCX1+)) into ischemic (or injured) myocardium

10.1371/journal.pone.0070023 · 2013 · External reference

Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells

10.1161/circulationaha.109.881441 · 2010 · External reference

Clinical trials of adult stem cell therapy for peripheral artery disease

10.14797/mdcj-9-4-201 · 2013 · External reference

Modulating the vascular response to limb ischemia: angiogenic and cell therapies

10.1161/circresaha.115.303565 · 2015 · External reference

Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells

10.1016/j.ahj.2014.07.021 · 2014 · External reference

Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies

10.1093/cvr/cvn039 · 2008 · External reference

Endothelial progenitor cells for postnatal vasculogenesis

10.1152/ajpcell.00330.2003 · 2004 · External reference

Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis

10.1016/j.ijcard.2015.06.038 · 2015 · External reference

Hematopoietic and endothelial differentiation of human induced pluripotent stem cells

10.1634/stemcells.2008-0922 · 2009 · External reference

Induction and isolation of vascular cells from human induced pluripotent stem cells—brief report

10.1161/atvbaha.108.182162 · 2009 · External reference

Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells

10.1371/journal.pone.0057876 · 2013 · External reference

Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds

10.1016/j.biomaterials.2014.07.011 · 2014 · External reference

Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells

10.1016/j.jtcvs.2007.12.053 · 2008 · External reference

Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction

10.1161/circimaging.108.767343 · 2008 · External reference

Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart

10.1161/circulationaha.107.732073 · 2008 · External reference

Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions

10.1161/circresaha.113.300219 · 2013 · External reference

Imaging survival and function of transplanted cardiac resident stem cells

10.1016/j.jacc.2008.12.036 · 2009 · External reference

“String theory” of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results

10.1161/circresaha.116.305557 · 2015 · External reference

Bone marrow cells regenerate infarcted myocardium

10.1038/35070587 · 2001 · External reference

Chimerism of the transplanted heart

10.1056/nejmoa012081 · 2002 · External reference

Evidence that human cardiac myocytes divide after myocardial infarction

10.1056/nejm200106073442303 · 2001 · External reference

Myocyte proliferation in end-stage cardiac failure in humans

10.1073/pnas.95.15.8801 · 1998 · External reference

Multilineage potential of adult human mesenchymal stem cells

10.1126/science.284.5411.143 · 1999 · External reference

Isolation and expansion of adult cardiac stem cells from human and murine heart

10.1161/01.res.0000147315.71699.51 · 2004 · External reference

Embryonic stem cell lines derived from human blastocysts

10.1126/science.282.5391.1145 · 1998 · External reference

Evidence for cardiomyocyte renewal in humans

10.1126/science.1164680 · 2009 · External reference

c-kit+ cells minimally contribute cardiomyocytes to the heart

10.1038/nature13309 · 2014 · External reference

Isolation of putative progenitor endothelial cells for angiogenesis

10.1126/science.275.5302.964 · 1997 · External reference

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

10.1161/01.res.85.3.221 · 1999 · External reference

Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion

10.1161/atvbaha.110.202796 · 2010 · External reference

Copy number variation and selection during reprogramming to pluripotency

10.1038/nature09871 · 2011 · External reference

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

10.1038/nature09798 · 2011 · External reference

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

10.1371/journal.pone.0120585 · 2015 · External reference

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

10.1016/j.stem.2010.12.003 · 2011 · External reference

Stem cells cruise to clinic

10.1038/494413a · 2013 · External reference

Epigenetic memory in induced pluripotent stem cells

10.1038/nature09342 · 2010 · External reference

The promise of induced pluripotent stem cells in research and therapy

10.1038/nature10761 · 2012 · External reference

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

10.1038/nbt1374 · 2008 · External reference

A comparison of non-integrating reprogramming methods

10.1038/nbt.3070 · 2015 · External reference

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

10.1016/j.stem.2010.12.008 · 2011 · External reference

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression

10.1371/journal.pone.0023657 · 2011 · External reference

Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions

10.1038/nprot.2012.150 · 2013 · External reference

Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells

10.1371/journal.pone.0126596 · 2015 · External reference

Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity

2013 · External reference

Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness

10.1073/pnas.1508073112 · 2015 · External reference

Immunogenicity of induced pluripotent stem cells

10.1038/nature10135 · 2011 · External reference

Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance

10.1038/ncomms4903 · 2014 · External reference

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

10.1038/nature11807 · 2013 · External reference

Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells

10.1016/j.stem.2013.01.006 · 2013 · External reference

Toward the development of a global induced pluripotent stem cell library

10.1016/j.stem.2013.08.003 · 2013 · External reference

Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types

10.1016/j.stem.2012.07.014 · 2012 · External reference

A more efficient method to generate integration-free human iPS cells

10.1038/nmeth.1591 · 2011 · External reference

The role of human leukocyte antigen matching in the development of multiethnic “haplobank” of induced pluripotent stem cell lines

10.1002/stem.772 · 2012 · External reference

Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury

10.1073/pnas.0910106107 · 2010 · External reference

Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation

10.1056/nejm200010123431504 · 2000 · External reference

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

10.1038/nm.3267 · 2013 · External reference

Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors

10.1073/pnas.1103509108 · 2011 · External reference

Engineering patient-specific valves using stem cells generated from skin biopsy specimens

10.1016/j.athoracsur.2014.04.075 · 2014 · External reference

“Transdifferentiation” of C6 glial cells in culture

10.1126/science.6102413 · 1980 · External reference

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

10.1016/j.cell.2010.07.002 · 2010 · External reference

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

10.1038/nature11044 · 2012 · External reference

Heart repair by reprogramming non-myocytes with cardiac transcription factors

10.1038/nature11139 · 2012 · External reference

Recent advances in direct cardiac reprogramming

10.1016/j.gde.2015.09.004 · 2015 · External reference

Labor pains of new technology: direct cardiac reprogramming

10.1161/circresaha.112.271445 · 2012 · External reference

Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels

10.1073/pnas.1205526109 · 2012 · External reference

Activation of innate immunity is required for efficient nuclear reprogramming

10.1016/j.cell.2012.09.034 · 2012 · External reference

Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity

10.1161/circulationaha.113.007394 · 2015 · External reference

Disease-specific induced pluripotent stem cells

10.1016/j.cell.2008.07.041 · 2008 · External reference

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

10.1056/nejmoa0908679 · 2010 · External reference

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

10.1038/nature09005 · 2010 · External reference

Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy

10.1126/scitranslmed.3003552 · 2012 · External reference

Microfluidic organs-on-chips

10.1038/nbt.2989 · 2014 · External reference

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies

10.1038/nm.3545 · 2014 · External reference

An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes

10.5966/sctm.2013-0105 · 2014 · External reference

Target identification and mechanism of action in chemical biology and drug discovery

10.1038/nchembio.1199 · 2013 · External reference

Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression

10.1038/nbt.2435 · 2012 · External reference

Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model

10.1093/toxsci/kft205 · 2013 · External reference

Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays

2013 · External reference

Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes

10.1073/pnas.1413481111 · 2014 · External reference

Functional vascular endothelium derived from human induced pluripotent stem cells

10.1016/j.stemcr.2013.06.007 · 2013 · External reference

iPSC disease modeling

10.1126/science.1227682 · 2012 · External reference

Developing optofluidic technology through the fusion of microfluidics and optics

10.1038/nature05060 · 2006 · External reference

High-throughput single-molecule optofluidic analysis

10.1038/nmeth.1569 · 2011 · External reference

Microfluidic heart on a chip for higher throughput pharmacological studies

10.1039/c3lc50350j · 2013 · External reference

Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip

10.1039/c1lc20557a · 2011 · External reference

Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells

10.1161/circulationaha.112.116996 · 2012 · External reference

Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy

10.1126/scitranslmed.3008008 · 2014 · External reference

Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy

10.1093/eurheartj/ehs226 · 2013 · External reference

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

10.1038/nature11799 · 2013 · External reference

Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells

10.1016/j.stem.2012.10.010 · 2013 · External reference

Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia

2013 · External reference

Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification

10.1093/hmg/ddr424 · 2011 · External reference

Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations

10.1371/journal.pone.0044660 · 2012 · External reference

Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia

10.1002/emmm.201100194 · 2012 · External reference

Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation

10.1111/j.1582-4934.2011.01476.x · 2012 · External reference

Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells

10.1016/j.jacc.2012.02.066 · 2012 · External reference

Modelling the long QT syndrome with induced pluripotent stem cells

10.1038/nature09747 · 2011 · External reference

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

10.1242/dmm.008409 · 2012 · External reference

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

10.1093/eurheartj/ehr073 · 2011 · External reference

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome

10.1038/nature09855 · 2011 · External reference